Onsdag 28 Oktober | 21:00:44 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Paxman Q1’23 - Trajectory intact

2023-05-25 07:42:00

Redeye sees continued sales progression driven by the right underlying factors. The scalp-cooling market transformation is underway, and the Q1 report confirms the positive trajectory for the long-term growth case we see in Paxman. With some minor adjustments to our estimates due to increasing macroeconomic uncertainty, we slightly lower the fair value range of SEK 39 to SEK 130 per share with a Base case value of SEK 86 per share.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/